U.S. Banks Stock News

If you are wondering whether Paychex at around US$102 per share still offers value or if the easy money has already been made, this article walks through what the current price tag really implies. Over the very short term, the stock has risen 5.6% in the last 7 days and 10.1% over the last 30 days, even though it remains down 5.7% year to date and has declined 32.3% over the past year. These moves are playing out against a backdrop where investors are reassessing many payroll and HR services...

Public Service Enterprise Group (NYSE:PEG) has completed a fixed-income offering of senior unsecured notes due 2031. The transaction adds a new tranche of fixed-rate debt to the company’s capital structure. The notes are expected to play a role in funding projects or refinancing existing obligations. For you as an investor, the new senior unsecured notes sit alongside NYSE:PEG’s regulated utility operations and related energy businesses. These businesses often require steady access to long...

TechnipFMC (NYSE:FTI) has appointed Eric D. Mullins to its Board of Directors and Audit Committee. Mullins is an experienced energy executive, co founder of Lime Rock Resources and a former Goldman Sachs banker. He also brings prior board experience at large energy companies, adding depth to TechnipFMC's governance structure. For investors watching TechnipFMC, the boardroom is now part of the story. The stock closed at $68.43, with the share price up 44.6% year to date and 120.2% over the...

Lincoln National (NYSE:LNC) has promoted three senior leaders into top executive roles, creating dedicated presidents for its Life Insurance and Annuities segments. The company has realigned its core business structure around these segments as part of a broader leadership refresh. Two long-serving executives are retiring, marking a transition in the company’s leadership team. Lincoln National recently held its annual shareholder meeting, with voting outcomes that affect board...

If you are wondering whether CVB Financial at around US$20.10 is still offering value after a solid run, the key is understanding what the current price actually reflects. The stock is up 7.7% year to date and 13.9% over the last year, although it has slipped around 1.2% over the past week and 1.7% over the past month, which may signal shifting views on risk and reward. Recent coverage has focused on CVB Financial's position within the US regional banking sector and how investor sentiment...

The Competition and Markets Authority has approved a joint venture in which Suzano will take a controlling interest in Kimberly-Clark’s international tissue operations. Kimberly-Clark has proposed a $49b acquisition of Kenvue, which is now under review by China’s competition regulator following an antitrust complaint. Both developments could reshape Kimberly-Clark’s business mix, geographic exposure and regulatory risk profile. These moves come as Kimberly-Clark (NasdaqGS:KMB) trades at...

Gold.com stock reaction Gold.com (GOLD) drew investor attention after a period of mixed share performance, with the stock down 6% over the past week, 7% over the past month, and 30% over the past 3 months. See our latest analysis for Gold.com. Despite the recent 1-day share price decline of 6.45% to US$39.58 and weaker short term momentum, the 1-year total shareholder return of 94.95% shows that longer term holders have still seen strong gains. If Gold.com’s swings have you thinking about...

Short term stock move SOLV Energy (MWH) has drawn investor attention after its stock declined about 10% over the past week and roughly 15% over the past month, even though year-to-date gains remain positive. See our latest analysis for SOLV Energy. Despite the recent pullback, with a 7 day share price return down 9.9% and a 30 day share price return down 14.8%, the 90 day share price return of 15.1% and year to date share price return of 12.9% suggest that momentum has cooled but not fully...

Niagen Bioscience, Inc. recently renamed its ChromaDex External Research Program as the Niagen Research Program and introduced a Trainee Grant Program to support new investigators in exercise performance and recovery, extending backing to more than 175 ongoing NAD+ studies worldwide. This refresh concentrates the company’s scientific identity squarely around its patented Niagen ingredient, underlining how deeply its brand is tied to NAD+ research collaborations. Next, we’ll consider how this...

Oculis Holding reported that its two Phase 3 DIAMOND trials of OCS-01 in diabetic macular edema did not meet primary or key secondary vision endpoints. The company will not pursue an FDA filing for OCS-01 in this indication and will instead focus resources on other late-stage ophthalmic drug candidates. Shares of NasdaqGM:OCS most recently closed at $14.51. For investors watching NasdaqGM:OCS, the update on OCS-01 represents a major reset for Oculis Holding, since this was a key late-stage...

If you are wondering whether American Tower at around US$187.53 is offering value or just adding noise to your portfolio, this article breaks down what the current price might really imply. The stock has recently returned 2.0% over 7 days and 3.3% over 30 days, with a year-to-date return of 7.3% but a decline of 9.2% over the past year and 18.8% over 5 years. Recent coverage has focused on American Tower within the wider real estate investment trust universe, with commentators paying close...

American Resources Corporation recently reported full-year 2025 results, moving from a net loss of US$39.12 million to net income of US$55.41 million, and in June 2026 began presenting at major events such as the 46th Annual William Blair Growth Stock Conference in Chicago. The company’s packed June conference schedule, centered on critical mineral supply chains, energy innovation, and recycling, places its leadership directly before investors, customers, and potential partners at a time...

QXO (NYSE:QXO) is pursuing a $17b acquisition of TopBuild, a move that would make it the second-largest building products distributor in North America. The company has arranged a $3b leveraged loan sale and issued $3b in senior notes to support the transaction. QXO has launched cash tender offers for TopBuild's outstanding debt as part of the deal's financing structure. The merger is drawing legal scrutiny, including shareholder lawsuits and class action inquiries focused on fiduciary duties...

EPAM Systems (NYSE:EPAM) has been removed from the S&P 500 index. The stock has been added to smaller capitalization indices, including the S&P 600 and S&P 1000. This index reshuffle signals a change in how EPAM is classified within major equity benchmarks. EPAM Systems now trades at $108.76, with the stock down 45.7% year to date and down 36.2% over the past year. Over a 5 year span, the share price is down 77.7%, a steep move that helps explain why NYSE:EPAM is migrating from a large cap...

If you are wondering whether UDR at around US$36.60 offers fair value, a bargain, or a risk you do not need, this article walks through the key signals that matter for you. The stock has been choppy recently, with the price declining 3.7% over the last week, edging up 0.6% over the last month, and sitting slightly down 0.2% year to date, while the 1 year return is also down 7.4%. Over a longer stretch, the stock is up 1.4% over 3 years but down 9.8% over 5 years. This helps frame how recent...

MP Materials (NYSE:MP) is expanding U.S. rare earth production, including a new magnet manufacturing facility. The company has signed long term supply agreements with Apple and the U.S. Department of Defense. MP Materials also entered a rare earth refinery development deal in Saudi Arabia. For investors watching critical materials, MP Materials sits at the intersection of rare earth mining and magnet manufacturing. The company is moving beyond exporting concentrates to China toward a more...

Those following along with The Charles Schwab Corporation ( NYSE:SCHW ) will no doubt be intrigued by the recent...

Readers hoping to buy Information Services Group, Inc. ( NASDAQ:III ) for its dividend will need to make their move...

Recent performance snapshot for Lionsgate Studios (LION) Lionsgate Studios (LION) has drawn investor attention after recent trading, with the stock closing at $13.86 and showing mixed short term returns alongside stronger longer term performance figures. See our latest analysis for Lionsgate Studios. While the share price slipped 3.4% over the past day and 7.3% over the past week, it still shows strong momentum overall, with a 90 day share price return of 52.6% and a 1 year total shareholder...

Crane stock snapshot and recent performance Crane (CR) gives investors exposure to engineered industrial products across aerospace and process flow markets, with shares last closing at US$182.05. The stock is up about 6% over the past month and down roughly 9% over the past 3 months. See our latest analysis for Crane. Recent trading points to fading short term momentum, with the share price down about 9.4% over three months. However, total shareholder returns of 7.1% over one year and very...

Gentherm stock snapshot after recent trading move Gentherm (THRM) has caught investor attention after a recent rebound in its share price, with the stock up 17.4% over the past month and 14.1% over the past 3 months based on provided data. See our latest analysis for Gentherm. The recent strength in Gentherm’s share price, including a 2.57% 1 day share price return and 8.67% over 7 days, comes against a mixed backdrop where the year to date share price return is down 3.39% but the 1 year...

If you have ever wondered whether NextEra Energy at around US$83.66 reflects a fair price or a stretch, this is a good moment to step back and test what the current tag might really mean for long term investors. The stock has slipped around 5.5% over the past week and about 13.7% over the past month, yet it is still up 3.4% year to date and around 21.8% over the past year, which can change how the risk and reward trade off feels right now. Recent news coverage has largely focused on the...

Capricor Therapeutics stock reaction and recent performance snapshot Capricor Therapeutics (CAPR) has drawn investor attention after recent trading moves, with the stock closing at US$28.53, as ongoing phase 3 work on its lead Duchenne muscular dystrophy therapy continues to shape sentiment. See our latest analysis for Capricor Therapeutics. Short term, the stock has cooled after its recent phase 3 developments, with the 1 day share price return down 4.8% and the 1 month share price return...

Rayonier (NYSE:RYN) has completed its merger with PotlatchDeltic earlier than initially planned. The combined timberland REIT is targeting substantial operational synergies across its enlarged portfolio. The deal reinforces Rayonier's focus on sustainable timberland management and expands its operating footprint. For shareholders, the timing of this merger comes after a challenging few years for NYSE:RYN, with the stock down 11.7% over 3 years and 22.9% over 5 years. The current share price...